598 related articles for article (PubMed ID: 35083887)
1. Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy.
Chesshyre M; Ridout D; Hashimoto Y; Ookubo Y; Torelli S; Maresh K; Ricotti V; Abbott L; Gupta VA; Main M; Ferrari G; Kowala A; Lin YY; Tedesco FS; Scoto M; Baranello G; Manzur A; Aoki Y; Muntoni F
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1360-1372. PubMed ID: 35083887
[TBL] [Abstract][Full Text] [Related]
2. Intelligence quotient-genotype association in dystrophinopathies: A systematic review and meta-analysis.
Pascual-Morena C; Cavero-Redondo I; Sequí-Domínguez I; Rodríguez-Gutiérrez E; Visier-Alfonso ME; Martínez-Vizcaíno V
Neuropathol Appl Neurobiol; 2023 Jun; 49(3):e12914. PubMed ID: 37312416
[TBL] [Abstract][Full Text] [Related]
3. Startle responses in Duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency.
Maresh K; Papageorgiou A; Ridout D; Harrison NA; Mandy W; Skuse D; Muntoni F
Brain; 2023 Jan; 146(1):252-265. PubMed ID: 35136951
[TBL] [Abstract][Full Text] [Related]
4. Global prevalence of intellectual developmental disorder in dystrophinopathies: A systematic review and meta-analysis.
Pascual-Morena C; Cavero-Redondo I; Álvarez-Bueno C; Jiménez-López E; Saz-Lara A; Martínez-García I; Martínez-Vizcaíno V
Dev Med Child Neurol; 2023 Jun; 65(6):734-744. PubMed ID: 36440509
[TBL] [Abstract][Full Text] [Related]
5. Natural History of a Mouse Model Overexpressing the Dp71 Dystrophin Isoform.
Lim KRQ; Shah MNA; Woo S; Wilton-Clark H; Zhabyeyev P; Wang F; Maruyama R; Oudit GY; Yokota T
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884423
[TBL] [Abstract][Full Text] [Related]
6. Subcellular localization of dystrophin isoforms in cardiomyocytes and phenotypic analysis of dystrophin-deficient mice reveal cardiac myopathy is predominantly caused by a deficiency in full-length dystrophin.
Masubuchi N; Shidoh Y; Kondo S; Takatoh J; Hanaoka K
Exp Anim; 2013; 62(3):211-7. PubMed ID: 23903056
[TBL] [Abstract][Full Text] [Related]
7. Brain Dp140 alters glutamatergic transmission and social behaviour in the mdx52 mouse model of Duchenne muscular dystrophy.
Hashimoto Y; Kuniishi H; Sakai K; Fukushima Y; Du X; Yamashiro K; Hori K; Imamura M; Hoshino M; Yamada M; Araki T; Sakagami H; Takeda S; Itaka K; Ichinohe N; Muntoni F; Sekiguchi M; Aoki Y
Prog Neurobiol; 2022 Sep; 216():102288. PubMed ID: 35654209
[TBL] [Abstract][Full Text] [Related]
8. Duchenne Muscular Dystrophy from Brain to Muscle: The Role of Brain Dystrophin Isoforms in Motor Functions.
Wijekoon N; Gonawala L; Ratnayake P; Amaratunga D; Hathout Y; Mohan C; Steinbusch HWM; Dalal A; Hoffman EP; de Silva KRD
J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685704
[TBL] [Abstract][Full Text] [Related]
9. Redefinition of dystrophin isoform distribution in mouse tissue by RT-PCR implies role in nonmuscle manifestations of duchenne muscular dystrophy.
Tokarz SA; Duncan NM; Rash SM; Sadeghi A; Dewan AK; Pillers DA
Mol Genet Metab; 1998 Dec; 65(4):272-81. PubMed ID: 9889014
[TBL] [Abstract][Full Text] [Related]
10. Ocular and neurodevelopmental features of Duchenne muscular dystrophy: a signature of dystrophin function in the central nervous system.
Ricotti V; Jägle H; Theodorou M; Moore AT; Muntoni F; Thompson DA
Eur J Hum Genet; 2016 Apr; 24(4):562-8. PubMed ID: 26081639
[TBL] [Abstract][Full Text] [Related]
11. Detection of Dystrophin Dp71 in Human Skeletal Muscle Using an Automated Capillary Western Assay System.
Kawaguchi T; Niba ETE; Rani AQM; Onishi Y; Koizumi M; Awano H; Matsumoto M; Nagai M; Yoshida S; Sakakibara S; Maeda N; Sato O; Nishio H; Matsuo M
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29789502
[TBL] [Abstract][Full Text] [Related]
12. Effects of dystrophin isoforms on signal transduction through neural retina: genotype-phenotype analysis of duchenne muscular dystrophy mouse mutants.
Pillers DA; Weleber RG; Green DG; Rash SM; Dally GY; Howard PL; Powers MR; Hood DC; Chapman VM; Ray PN; Woodward WR
Mol Genet Metab; 1999 Feb; 66(2):100-10. PubMed ID: 10068512
[TBL] [Abstract][Full Text] [Related]
13. Age, corticosteroid treatment and site of mutations affect motor functional changes in young boys with Duchenne Muscular Dystrophy.
Coratti G; Lenkowicz J; Norcia G; Lucibello S; Ferraroli E; d'Amico A; Bello L; Pegoraro E; Messina S; Ricci F; Mongini T; Berardinelli A; Masson R; Previtali SC; D'angelo G; Magri F; Comi GP; Politano L; Passamano L; Vita G; Sansone VA; Albamonte E; Panicucci C; Bruno C; Pini A; Bertini E; Patarnello S; Pane M; Mercuri E;
PLoS One; 2022; 17(7):e0271681. PubMed ID: 35905042
[TBL] [Abstract][Full Text] [Related]
14. Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy.
Doorenweerd N; Straathof CS; Dumas EM; Spitali P; Ginjaar IB; Wokke BH; Schrans DG; van den Bergen JC; van Zwet EW; Webb A; van Buchem MA; Verschuuren JJ; Hendriksen JG; Niks EH; Kan HE
Ann Neurol; 2014 Sep; 76(3):403-11. PubMed ID: 25043804
[TBL] [Abstract][Full Text] [Related]
15. Altered visual processing in the mdx52 mouse model of Duchenne muscular dystrophy.
Barboni MTS; Liber AMP; Joachimsthaler A; Saoudi A; Goyenvalle A; Rendon A; Roger JE; Ventura DF; Kremers J; Vaillend C
Neurobiol Dis; 2021 May; 152():105288. PubMed ID: 33556541
[TBL] [Abstract][Full Text] [Related]
16. Dystrophin Genotype and Risk of Neuropsychiatric Disorders in Dystrophinopathies: A Systematic Review and Meta-Analysis.
Pascual-Morena C; Cavero-Redondo I; Martínez-Vizcaíno V; Sequí-Domínguez I; Fernández-Bravo-Rodrigo J; Jiménez-López E
J Neuromuscul Dis; 2023; 10(2):159-172. PubMed ID: 36565132
[TBL] [Abstract][Full Text] [Related]
17. Disrupted structural connectome and neurocognitive functions in Duchenne muscular dystrophy: classifying and subtyping based on Dp140 dystrophin isoform.
Preethish-Kumar V; Shah A; Polavarapu K; Kumar M; Safai A; Vengalil S; Nashi S; Deepha S; Govindaraj P; Afsar M; Rajeswaran J; Nalini A; Saini J; Ingalhalikar M
J Neurol; 2022 Apr; 269(4):2113-2125. PubMed ID: 34505932
[TBL] [Abstract][Full Text] [Related]
18. Altered presynaptic ultrastructure in excitatory hippocampal synapses of mice lacking dystrophins Dp427 or Dp71.
Miranda R; Nudel U; Laroche S; Vaillend C
Neurobiol Dis; 2011 Jul; 43(1):134-41. PubMed ID: 21397023
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
20. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy.
Miyatake S; Mizobe Y; Takizawa H; Hara Y; Yokota T; Takeda S; Aoki Y
Methods Mol Biol; 2018; 1687():123-141. PubMed ID: 29067660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
